12月3日，由瞭望周刊社主办，瞭望智库承办的"新趋势 新生态 新机遇——2025食品与健康智库论坛"在海南博鳌成功 举办。作为2025企业家博鳌论坛平行论坛，以"十五五"时期健康中国建设为核心背景，聚焦食品与健康产业高质量发 展路径，深入探讨产业升级新方向。与会嘉宾达成共识，食品与健康产业是健康中国建设的基石，其高质量发展必须 坚守安全底线、夯实营养内核、驱动创新引擎。小仙炖鲜炖燕窝作为该论坛燕窝行业指定产品和贵宾专用产品重磅亮 相，以中式滋补的创新实践与品质坚守，为健康中国建设注入鲜活滋补力量。 锚定产业新趋势：全链把控筑牢健康根基 在全产业链把控上，小仙炖构建了"从原料产区到餐桌"的全链路品质防线。燕窝品质始于原料，小仙炖供应链与科研 团队深入马来西亚、印尼核心产区，建立涵盖气候、生态环境、养殖规范等多维度的严苛产区筛选标准。从产区的年 平均湿度、降水量，到森林覆盖率、水系清洁度，再到产区生态的原始性与稳定性，每一项指标均经过实地勘察、数 据核验与长期跟踪。在符合标准的特级产区，其与当地合作方签订专属燕屋协议，按《燕窝产地等级划分》标准对燕 屋选址、环境管控、采摘规范等实施全流程监管，旗下加里曼之星产品原 ...

Core Insights - The visit by representatives from the Guangdong Province Bird's Nest Industry Association and other regional enterprises to Xiaoxiansen (Shanghai) highlights the growing interest in the bird's nest industry and its potential for innovation and collaboration [1][4] Group 1: Company Overview - Xiaoxiansen focuses on fresh bird's nest products and has established a successful model with nine direct stores in the same city [5] - The company integrates research and development, production, and sales, adhering to the principle of providing affordable health supplements [5] - Xiaoxiansen actively participates in industry standard formulation, contributing to the release of the "Edible Bird's Nest Group Standard" to promote industry regulation and high-quality development [5] Group 2: Industry Development - The visiting delegation explored the new "Exploration Journey" bird's nest experience center, showcasing the integration of art, technology, and culture in the industry [3] - Discussions among industry representatives emphasized the need for innovation in product development and collaborative growth across the supply chain to enhance the traditional Chinese health supplement sector [3] - The consensus among participants was that high-quality industry development must be rooted in quality and driven by innovation, fostering a symbiotic industrial ecosystem [3]

Core Points - The national standard for food traceability system evaluation (GB/T 46453—2025) has been officially released, with Yan Zhi Wu being the only nest industry company involved in its formulation [1] - Yan Zhi Wu has integrated its extensive experience in quality and safety control throughout the entire nest industry chain into the standard development process [1] - The company has established a product traceability system that covers the entire lifecycle, adhering to the highest requirements of the new national standard [1] Industry Standards - Yan Zhi Wu has led the drafting and release of two industry standards in the nest industry, including the first domestic standard for nest quality grading in 2014, which ended the long-standing lack of standards in the industry [1] - In 2023, the company also led the drafting of the first industry standard for nest products, filling a significant gap in the standards for nest products in China [1] - Since 2014, in addition to the two major industry standards, Yan Zhi Wu has participated in drafting one testing method industry standard and 24 group standards [1]

Core Insights - The health industry is experiencing strong demand while undergoing transformation, with consumers seeking diversified experiences rather than single solutions [1] - Companies that can quickly adapt to these trends are likely to secure long-term growth opportunities [1] Company Performance - Yanzhiwu achieved revenue of 1.01 billion yuan in the first half of the year, a slight year-on-year decline, while net profit increased by 28.98% to 77.45 million yuan [2] - E-commerce revenue accounted for 62.36% of total revenue, indicating a shift towards online sales [2] - Yanzhiwu maintained its leading position in the industry, receiving multiple certifications such as "first in high-end bird's nest sales" and "first in bird's nest specialty store numbers" [2] Product Innovation - Yanzhiwu is expanding its product lines, including the successful launch of "Xiao Yan Nong Bird's Nest Porridge," which generated sales of 43.82 million yuan, a year-on-year increase of 6.28% [2] - The company is also innovating with new products like "supercritical fresh hot bird's nest" and "bird's nest + probiotics," enhancing its product ecosystem [5][6] Strategic Pathways - Yanzhiwu is pursuing three strategic pathways: "product innovation," "channel expansion," and "brand elevation" to drive its transformation [4] - The company is enhancing its sales network through both online and offline channels, including the establishment of 712 offline stores and expansion into international markets [8] Market Position and Valuation - The Hong Kong stock market is experiencing liquidity improvements, with a focus on technology and new consumption sectors, creating opportunities for companies like Yanzhiwu [10] - Yanzhiwu has initiated share buybacks, signaling confidence in its future prospects and indicating that it is undervalued in the market [10]

Core Insights - Yan Zhi Wu (1497.HK) reported a revenue of RMB 1.01 billion and a net profit of RMB 77.45 million for the six months ending June 30, 2025, representing a year-on-year growth of 28.98% and 35.54% respectively for adjusted net profit [1] Group 1: Financial Performance - Revenue reached RMB 1.01 billion, showing a significant increase compared to the previous year [1] - Net profit was RMB 77.45 million, reflecting a year-on-year growth of 28.98% [1] - Adjusted net profit stood at RMB 81.39 million, with a year-on-year increase of 35.54% [1] Group 2: Business Strategy - The company leverages strong research capabilities to diversify its product matrix in the bird's nest market [1] - Yan Zhi Wu adopts a multi-faceted and differentiated product strategy to reach a broader consumer base [1] - The company is actively responding to market changes while maintaining a prudent operational strategy [1] Group 3: Market Expansion - Yan Zhi Wu is focused on strengthening existing channels and accelerating overseas business expansion [1] - Continuous optimization of production efficiency has effectively reduced production costs, enhancing product competitiveness [1] Group 4: Future Outlook - The company plans to deepen its core strategy of "mining the value of bird's nest and expanding the health ecosystem" [1] - There is a focus on the diversification and personalization of consumer demands [1] - Yan Zhi Wu aims to launch more compound nourishment solutions to solidify its leadership position in the health consumption market [1]

Core Insights - The article highlights the participation of Miaoshu, the Chairman and CEO of Xiaoxian Stewed Bird's Nest, at the 2025 Xipu Conference, where he shared insights on category innovation and the success logic behind the brand's growth in the health industry [1][4]. Company Overview - Xiaoxian Stewed Bird's Nest has achieved the leading position in fresh stewed bird's nest sales in China for eight consecutive years, driven by its innovative product category that addresses consumer pain points [4][5]. - The brand has identified key consumer challenges such as difficulty in identifying raw materials, lack of time for preparation, and uncertainty about the nutritional benefits of bird's nest, which led to the creation of the fresh stewed bird's nest category [5][9]. Innovation and Growth Strategy - The company has implemented a systematic innovation approach across multiple dimensions, including supply chain management, standardization, research, and channel development [9]. - Xiaoxian has established exclusive partnerships in key bird's nest production areas globally and has created the first-ever global standard for bird's nest origin classification, enhancing consumer trust [9]. - The brand has conducted scientific research to validate the health benefits of bird's nest, collaborating with academic institutions to publish findings in reputable journals [12][17]. Market Potential - Experts believe that the fresh stewed bird's nest category has significant growth potential, with projections suggesting it could reach a market size of 10 billion [8]. - The company is focusing on consumer engagement by providing tailored health solutions and deepening communication around the benefits of bird's nest, thereby reinforcing its market position [17]. Industry Impact - Xiaoxian's innovative practices are seen as a model for growth in the health industry, emphasizing user-centric value innovation and establishing category barriers [17].

Core Viewpoint - Anjuke Foods, a leading player in the frozen food industry, has successfully listed on the Hong Kong Stock Exchange, marking a significant milestone in its growth trajectory and reflecting the increasing trend of companies from Xiamen going public in Hong Kong [3][4]. Company Overview - Anjuke Foods was founded in 2001 and has become the largest frozen food company in China, holding a market share of 6.6% as of 2024. It leads the frozen prepared food market with a 13.8% share, significantly outpacing its closest competitor [3]. - The company reported a revenue of 15.127 billion yuan in 2024, a 7.7% increase from the previous year, while its net profit saw a marginal increase of 0.46% to 1.485 billion yuan [13]. Historical Growth - Anjuke Foods' revenue has grown from 3.484 billion yuan in 2017 to 15.127 billion yuan in 2024, showcasing a remarkable growth trajectory over eight years [3]. - The company has strategically avoided direct competition with major players by focusing on niche markets and leveraging its geographical advantages in Fujian [7][9]. Market Challenges - Despite its strong market position, Anjuke Foods faces challenges such as increased competition from new brands and fluctuating raw material prices, which have impacted its profit margins [14]. - The company's revenue growth rate has been declining, with a significant drop in net profit growth from 61.44% in 2022 to just 0.47% in 2024 [13][14]. Strategic Initiatives - To address its performance challenges, Anjuke Foods is increasing its R&D investments to innovate and launch new products that meet evolving consumer demands [14]. - The company is also focusing on expanding its market presence in Southeast Asia, particularly in Indonesia and Malaysia, where it sees significant growth potential [15]. IPO Trends in Xiamen - Anjuke Foods is part of a broader trend of Xiamen-based companies going public in Hong Kong, with over 20 companies currently in the pipeline for IPOs [4][17]. - The successful listing of Anjuke Foods is expected to enhance the visibility and attractiveness of Xiamen as a hub for capital market activities [17].

Core Viewpoint - The establishment of the "Xiamen Nest and Nest Peptide Quality Control and Health Efficacy Application Joint Laboratory" marks a significant collaboration among Xiamen Customs Technology Center, Fujian Agriculture and Forestry University, and Yan Zhi Wu, aimed at enhancing the quality and health efficacy of the nest industry through technological innovation [2][3]. Group 1 - The joint laboratory aims to address core issues in the nest industry, such as authenticity verification, quality standards, and efficacy validation, driven by the increasing consumer demand for health products [2][3]. - The collaboration leverages the strengths of government, academia, and industry to overcome technical bottlenecks in quality control and explore the health efficacy mechanisms of nests and nest peptides [2][3][5]. - The laboratory's goals include establishing a reliable quality control system, investigating the scientific mechanisms of health efficacy, and accelerating the industrialization of research outcomes [3][5]. Group 2 - The partnership signifies a new phase of deep integration between industry, academia, and research, enhancing the global competitiveness of the Xiamen nest industry [3]. - Yan Zhi Wu, with 27 years of focus on high-quality nests, aims to lead the industry towards standardization and technological advancement, becoming the first listed company in China's nest industry [2][5]. - The joint laboratory is envisioned as an efficient platform for research breakthroughs, technological innovation, outcome transformation, and talent cultivation in the nest industry [5].

Core Viewpoint - Yan Zhi Wu's shift from targeting affluent women to focusing on middle-aged men may not be sufficient to revitalize its brand and sales performance, as evidenced by declining profits and changing consumer preferences [3][5][30]. Financial Performance - In 2024, Yan Zhi Wu reported revenue of 2.05 billion, a year-on-year increase of 4.37%, while net profit fell to 160 million, a decline of 24.18%, marking the first negative growth in net profit in five years [3][15][16]. - The company's online visitor count reached 340 million, up 47.9%, and online orders increased by 36.2%, indicating a disparity between interest and actual purchases [15][16]. Marketing Strategy - The brand has recently engaged Vanke founder Wang Shi as a spokesperson for its new men's product line, which is priced significantly higher than its women's offerings, reflecting a strategy to appeal to a different demographic [4][11][24]. - Yan Zhi Wu's marketing expenses grew by 19.1% in 2024, while revenue only increased by less than 5%, leading to a sales expense ratio of 32%, up from 24-26% in previous years [23][22]. Market Positioning - The brand's attempt to market "men's燕窝" (bird's nest) products is seen as a desperate measure to capture a new customer base, as traditional female-targeted strategies have become less effective [24][35]. - The introduction of products aimed at men, such as the "总裁碗燕" (CEO bowl bird's nest), raises questions about market education and consumer acceptance, given the historical association of燕窝 with women's beauty and health [35][37]. Consumer Response - Initial sales figures for the new product line have been disappointing, with only 65 purchases recorded shortly after launch, suggesting a lack of consumer interest or acceptance [31][32].

Core Viewpoint - Yan Zhi Wu has received the "world's first patent authorization for the efficacy and application of bird's nest peptides," marking a significant advancement in the industry and establishing a benchmark for scientific validation and industrial transformation [1][11]. Group 1: Patent and Technology - The patent granted to Yan Zhi Wu is for a method of preparing bird's nest peptides that promote cell repair and provide high moisturizing and whitening effects (Patent No: ZL 2022 11398048.3) [1][4]. - The patented technology clarifies the enzymatic hydrolysis process of bird's nest peptides, revealing their properties such as moisturizing, whitening, and antioxidant effects, thus overcoming the industry's previous limitations of vague components and effects [3][4]. - The enzymatic hydrolysis process involves precise control to produce small molecular peptides with an average molecular weight of less than 1000 Da, enhancing the bioavailability of active ingredients [3][4]. Group 2: Research and Development - Yan Zhi Wu established a bird's nest peptide research center in January 2022, focusing on enzymatic technology, active ingredient research, and product development, achieving significant breakthroughs published in international journals [4]. - The company has received multiple industry awards, including the "Bird's Nest Peptide - Industry Innovation Award" in 2023, recognizing its contributions to the development of the bird's nest industry [4][5]. - In 2024, Yan Zhi Wu's bird's nest peptides were awarded the "Top 10 Chinese Innovative Raw Materials" and "Chinese Ace Ingredient Award," further solidifying its leadership in the field [4][8]. Group 3: Product Development - In 2022, Yan Zhi Wu launched its skincare brand "YAN PALACE," featuring small molecular bird's nest peptides as core ingredients, developing products like multi-effect facial masks and essence [8]. - The company was recognized by Frost & Sullivan as the "pioneer of bird's nest peptide skincare products" based on comparative research of Chinese skincare products [8][11]. - Yan Zhi Wu aims to provide healthier skincare experiences for women, promoting the concept of "bird's nest peptides advocating a new skin ecology" [8][9].